• Wed, August 9, 2023
Samantha Semenkow Maintained (BEAM) at Strong Buy with Decreased Target to $56 on, Aug 9th, 2023
Samantha Semenkow of Citigroup, Maintained "Beam Therapeutics Inc." (BEAM) at Strong Buy with Decreased Target from $60 to $56 on, Aug 9th, 2023.
Samantha has made no other calls on BEAM in the last 4 months.
There is 1 other peer that has a rating on BEAM. Out of the 1 peers that are also analyzing BEAM, all agrees with Samantha's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Luca Issi of "RBC Capital" Maintained at Hold with Decreased Target to $42 on, Thursday, May 11th, 2023
Like: 👍
